Pea F; Viale P; Lugano M; Baccarani U; Pavan F; Tavio M; Adani GL; Della Rocca G; Furlanut M., Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2009, 63, pp. 167 - 169 [articolo]
Pea F; Furlanut M, Chapter 219 - Principles of pharmacodynamics and pharmacokinetics of drugs used in extracorporeal therapies, in: Critical Care Nephrology - 2nd edition, USA, Saunders Elsevier, 2009, pp. 1190 - 1194 [commento giuridico]
Pea F; Viale P, Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?, «THE JOURNAL OF TRAUMA, INJURY, INFECTION, AND CRITICAL CARE», 2009, 66, pp. 348 - 1343 [articolo]
Pea F; Viale P, Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?, «THERAPEUTIC DRUG MONITORING», 2009, 21, pp. 135 - 136 [replica/breve intervento]
Pea F; Furlanut M; Viale P, Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients?, «ANAESTHESIA AND INTENSIVE CARE», 2009, 37, pp. 323 - 324 [articolo]
Pea F.; Viale P., Is the minimum inhibitory concentration of vancomycin an infallible predictor of the clinical outcome of staphylococcus aureus bacteremia treated with vancomycin?, «CLINICAL INFECTIOUS DISEASES», 2009, 49, pp. 642 - 643 [replica/breve intervento]
Pea F., Penetration of antibacterials into bone: What do we really need to know for optimal prophylaxis and treatment of bone and joint infections?, «CLINICAL PHARMACOKINETICS», 2009, 48, pp. 125 - 127 [replica/breve intervento]
Pea, Federico, [PK/PD profile and post-marketing surveillance of levofloxacin], «LE INFEZIONI IN MEDICINA», 2009, 17 Suppl 5, pp. 13 - 22 [articolo]
Pea F.; Furlanut M.; Negri C.; Pavan F.; Crapis M.; Cristini F.; Viale P., Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2009, 53, pp. 1863 - 1867 [articolo]
Scaglione F.; Bertazzoni Minelli E.; De Sarro A.; Esposito S.; Legnani D.; Mazzei T.; Mini E.; Passali D.; Pea F.; Stefani S.; Viano I.; Novelli A., The Charta of Milan: Basic criteria for the appropriate and accurate use of antibiotics: Recommendations of the Italian society of chemotherapy, «JOURNAL OF CHEMOTHERAPY», 2009, 21, pp. 475 - 481 [articolo]
Viale P.; Furlanut M.; Scudeller L.; Pavan F.; Negri C.; Crapis M.; Zamparini E.; Zuiani C.; Cristini F.; Pea F., Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2009, 33, pp. 379 - 382 [articolo]
Pea F; Furlanut M; Viale P, What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2009, 53, pp. 3608 - 3609 [replica/breve intervento]
Pea F; Furlanut M, Chapter 17 - General considerations in cardiothoracic critical care: importance of pharmacokinetics, in: Core topics in cardiothoracic critical care, USA, Cambridge University Press, 2008, pp. 123 - 126 [commento giuridico]
Pea F.; Pavan F.; Furlanut M., Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients, «CLINICAL PHARMACOKINETICS», 2008, 47, pp. 449 - 462 [articolo]
Pea, F; Tavio, M; Pavan, F; Londero, A; Bresadolo, V; Adani, GL; Furlanut, M; Viale, P, Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients, «ANTIVIRAL THERAPY», 2008, 13, pp. 739 - 742 [articolo]
